[These findings provide the missing confirmation that RB2/p130 is a `bona fide` tumor suppressor gene and strengthen the hypothesis that it may be a candidate for cancer gene therapy for lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE